Skip to search boxSkip to navigationSkip to main content

Functional significance of protein kinase A activation by endothelin-1 and ATP: Negative regulation of SRF-dependent gene expression by PKA

  • Amanda Davis
    ,
  • Kyle Hogarth
    ,
  • Darren Fernandes
    ,
  • Julian Solway
    ,
  • Jiaxin Niu
    ,
  • Vladimir Kolenko
*Corresponding author for this work
  • The University of Chicago
    ,
  • University of Illinois at Chicago
    ,
  • Boston Biomedical Research Institute
    ,
  • ,
  • University of Rochester
    ,
  • Centre Hospitalier de L'Universite de Montreal
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

Endothelin-1 (ET1) and ATP stimulate contraction and hypertrophy of vascular smooth muscle cells (VSMC) by activating diverse signalling pathways. In this study, we show that in VSMC, ET1 and ATP stimulate transient and sustained activation of protein kinase A (PKA), respectively. Using a dominant negative PKA mutant (PKA-DN), we examined the functional significance of PKA activation in the signalling of ET1 and ATP. Overexpression of PKA-DN did not alter the ET1- or ATP-induced phosphorylation of the extracellular signal-regulated protein kinase, Erk2. ATP stimulated a profound, PKA-dependent activation of cAMP-response element (CRE), whereas the effect of ET1 was negligible. Both ET1 and ATP stimulated serum response factor (SRF)-dependent gene expression. Overexpression of PKA-DN potentiated the effects of ET1 and ATP on SRF activity, whereas stimulation of PKA by isoproterenol, forskolin or by overexpression of the PKA catalytic subunit decreased SRF activity. These data demonstrate that (i) PKA negatively regulates SRF activity and (ii) ET1 and ATP stimulate opposing pathways, whose balance determines the net activity of SRF.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 597-604 (8 pages)

Journal (Volume, Issue Number)

Cellular Signalling (Volume 15, Issue 6)

Publication milestones

  • Published - 06/01/2003

Publication status

Published - 06/01/2003

ISSN

0898-6568

Publication IDs

  • Scopus: 0037409295
  • PubMed: 12681447

Publication metrics

Metrics

SciVal
citations
39
Scopus
citations
SciVal
FWCI
0.42
SciVal
Author count
10
SciVal
Paper percentile
82
Fractional count
2
Fractional count
0.20
Fractional count
8
Fractional count
0.80
Fractional count
2
Fractional count
1

PlumX, opens in new tab

Captures
20
Citation count
39

Funding Details

We thank Dr. Michael Uhler for providing FLAG-VASP cDNA, Dr. Stanley McKnight for providing PKA-DN cDNA, Dr. Louis Luttrell and Dr. Nigel Bunnett for providing Erk2-GFP cDNA, Dr. Tatyana Voyno-Yasenetskaya for providing SRE.L-luciferase reporter plasmid, Dr. Gary Owens for providing SM α-actin-CAT reporter plasmid and Dr. Michael Dunn for providing Erk1/2 antibodies. This study was supported by American Heart Association (NOD), NIH grants HL56399 (JS), HL64095 (JS), HL62572 (JMM) and Glaxo Smith Kline (JS).
FundersFunding numbers
Glaxo Smith Kline
-
NOD
-
NIH
HL62572, HL56399
NHLBI
R01HL064095
AHA
-